GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 21, 2024
Displaying entries 2251 - 2300 of 39437 in total
PDB ID UniProt ID ▲ Title Descriptor
5UJZ 5UJZ CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 1 Hemagglutinin HA1, Hemagglutinin HA2, scFv
5UK0 5UK0 CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 2 Hemagglutinin HA1, Hemagglutinin HA2, scFV
5UK1 5UK1 CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 3 Hemagglutinin HA1, Hemagglutinin HA2, scFv
5UK2 5UK2 CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 4 Hemagglutinin HA1, Hemagglutinin HA2, scFv
5UKR 5UKR Structure of unliganded anti-gp120 CD4bs antibody DH522.2 Fab in complex with a gp120 core
5UM8 5UM8 Crystal structure of HIV-1 envelope trimer 16055 NFL TD CC (T569G) in complex with Fabs 35022 and PGT124
5UMN 5UMN Crystal structure of C05 VPGSGW mutant bound to H3 influenza hemagglutinin, HA1 subunit
5UN8 5UN8 Crystal Structure of human O-GlcNAcase in complex with glycopeptide p53
5UOW 5UOW Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, MK-801 and a GluN2B-specific Fab, at pH 6.5 N-methyl-D-aspartate receptor subunit NR1-8a, N-methyl-D-aspartate receptor subunit NR2A, Ionotropic glutamate receptor subunit NR2B, chain F
5UP2 5UP2 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2B in complex with glycine, glutamate, Ro 25-6981, MK-801 and a GluN2B-specific Fab, at pH 6.5 N-methyl-D-aspartate receptor subunit NR1-8a, N-methyl-D-aspartate receptor subunit NR2A, Ionotropic glutamate receptor subunit NR2B, chainF
5UQY 5UQY Crystal structure of Marburg virus GP in complex with the human survivor antibody MR78
5UTF 5UTF Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M in Complex with Human Antibodies PGT122 and 35O22 at 4.3 A
5UTY 5UTY Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations I201C-P433C (DS), L154M, N300M, N302M, T320L in Complex with Human Antibodies PGT122 and 35O22 at 4.1 Angstrom
5UUY 5UUY Crystal structure of Dioclea lasiocarpa lectin (DLL) complexed with X-MAN
5V2A 5V2A Crystal structure of Fab H7.167 in complex with influenza virus hemagglutinin from A/Shanghai/02/2013 (H7N9)
5V4M 5V4M Structure of HLA-DR15 with bound alpha3(135-145) peptide HLA-DRA1, alpha3(135-145)-HLA-DRB1*15:01
5V4M 5V4M Structure of HLA-DR15 with bound alpha3(135-145) peptide HLA-DRA1, alpha3(135-145)-HLA-DRB1*15:01
5V4N 5V4N Structure of HLA-DR1 with bound alpha3(135-145) peptide
5V4N 5V4N Structure of HLA-DR1 with bound alpha3(135-145) peptide
5V7J 5V7J Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22.
5V8L 5V8L BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 gp120, gp41, 3BNC117 antibody, heavy chain, PGT145 antibody, heavy chain, 3BNC117 antibody, light chain, PGT145 antibody, light chain
5V8M 5V8M BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 gp120, gp41, antibody 3BNC117, heavy chain, antibody 3BNC117, light chain
5VAK 5VAK Crystal Structure of Beta-Klotho, Domain 1 Beta-klotho, Nb914
5VAN 5VAN Crystal Structure of Beta-Klotho Beta-klotho, Nb914
5VAQ 5VAQ Crystal Structure of Beta-Klotho in Complex with FGF21CT Beta-klotho, Nb914, Fibroblast growth factor 21
5VCJ 5VCJ Structure of alpha-galactosylphytosphingosine bound by CD1d and in complex with the Va14Vb8.2 TCR
5VCN 5VCN THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
5VCO 5VCO THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
5VEB 5VEB Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6
5VEB 5VEB Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6
5VF2 5VF2 scFv 2D10 re-refined as a complex with trehalose replacing the original alpha-1,6-mannobiose
5VGJ 5VGJ Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain
5VH5 5VH5 Crystal Structure of Fc fragment of anti-TNFa antibody infliximab
5VIE 5VIE Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase
5VIF 5VIF Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VK2 5VK2 Structural basis for antibody-mediated neutralization of Lassa virus
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VLI 5VLI Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934)
5VN3 5VN3 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN8 5VN8 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOB 5VOB Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC 5VOC Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOC 5VOC Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein
5VOD 5VOD Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6
5VOD 5VOD Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6
5VPG 5VPG CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024